{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T06:47:38Z","timestamp":1784875658885,"version":"3.55.0"},"publisher-location":"Chichester, UK","reference-count":57,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd003552.pub2","type":"reference-entry","created":{"date-parts":[[2008,2,5]],"date-time":"2008-02-05T20:11:33Z","timestamp":1202242293000},"source":"Crossref","is-referenced-by-count":13,"title":["Skin patch and vaginal ring versus combined oral contraceptives for contraception"],"prefix":"10.1002","author":[{"given":"Laureen M","family":"Lopez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Grimes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria F","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth F","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,1,23]]},"reference":[{"key":"10.1002\/14651858.CD003552.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.contraception.2006.07.004","article-title":"Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 3 \u00b5g of ethinyl estradiol and 3 mg of drospirenone","volume":"74","author":"Ahrendt","year":"2006","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD003552.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/humrep\/del162","article-title":"Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 \u00b5g ethinyl estradiol and 3 mg drospirenone","volume":"21","author":"Milsom","year":"2006","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003552.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1001\/jama.285.18.2347","article-title":"Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial","volume":"285","author":"Audet","year":"2001","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD003552.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1067\/mob.2002.118844","article-title":"Transdermal contraception: evaluation of three transdermal norelgestromin\/ethinyl estradiol doses in a randomized, multicenter, dose-response study","volume":"186","author":"Dittrich","year":"2002","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD003552.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/13625180400007199","article-title":"A comparative study on the effects of a contraceptive vaginal ring NuvaRing and an oral contraceptive on carbohydrate metabolism and adrenal and thyroid function","volume":"9","author":"Duijkers","year":"2004","journal-title":"European Journal of Contraception and Reproductive Health Care"},{"key":"10.1002\/14651858.CD003552.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/humrep\/deh686","article-title":"Effects of two types of hormonal contraception--oral versus intravaginal--on the sexual life of women and their partners","volume":"20","author":"Guida","year":"2005","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003552.pub2-BIB8|cit7","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.contraception.2004.09.001","article-title":"Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial","volume":"71","author":"Oddsson","year":"2005","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD003552.pub2-BIB7|cit8","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/humrep\/deh604","article-title":"Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 \u00b5g ethinylestradiol and 150 \u00b5g levonorgestrel: a randomized trial","volume":"20","author":"Oddsson","year":"2005","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003552.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ajog.2005.12.007","article-title":"Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables","volume":"195","author":"Rad","year":"2006","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD003552.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.contraception.2007.01.027","article-title":"Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen","volume":"75","author":"Sitruk-Ware","year":"2007","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD003552.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.contraception.2006.03.022","article-title":"Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives","volume":"74","author":"Sabatini","year":"2006","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD003552.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0020-7292(00)85161-9","article-title":"Comparison of efficacy, cycle control, compliance and safety in users of a contraceptive patch vs an oral contraceptive","volume":"70","author":"Hedon","year":"2000","journal-title":"International Journal of Gynaecology and Obstetrics"},{"key":"10.1002\/14651858.CD003552.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejogrb.2005.01.021","article-title":"Contraceptive efficacy, compliance and beyond: factors related to satisfaction with once-weekly transdermal compared with oral contraception","volume":"121","author":"Urdl","year":"2005","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"key":"10.1002\/14651858.CD003552.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/01.AOG.0000136082.59644.13","article-title":"A comparison between the vaginal ring and oral contraceptives","volume":"104","author":"Veres","year":"2004","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD003552.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.contraception.2005.05.008","article-title":"Measured and reported weight change for women using a vaginal contraceptive ring vs. a low-dose oral contraceptive","volume":"72","author":"O'Connell","year":"2005","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD003552.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.contraception.2005.11.003","article-title":"Acceptability and satisfaction using Quick Start with the contraceptive vaginal ring versus an oral contraceptive","volume":"73","author":"Schafer","year":"2006","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD003552.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/01.AOG.0000164483.13326.59","article-title":"Bleeding patterns after immediate initiation of an oral compared with a vaginal hormonal contraceptive","volume":"106","author":"Westhoff","year":"2005","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD003552.pub2-BIB18|cit18","doi-asserted-by":"crossref","unstructured":"Archer D Bigrigg A Smallwood G Shangold G Creasy G An integrated assessment of patient compliance with a weekly contraceptive patch (ORTHO EVRA \/ EVRA) Fertility and Sterility 2001 20","DOI":"10.1016\/S0015-0282(01)02082-9"},{"key":"10.1002\/14651858.CD003552.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0015-0282(01)03263-0","article-title":"Assessment of compliance with a weekly contraceptive patch (Ortho Evra\u2122\/Evra\u2122) among North American women","volume":"77","author":"Archer","year":"2002","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD003552.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.contraception.2003.10.006","article-title":"The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra) on contraceptive efficacy","volume":"69","author":"Archer","year":"2004","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD003552.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1067\/mob.2002.121103","article-title":"Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel\/ethinyl estradiol","volume":"186","author":"Bjarnadottir","year":"2002","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD003552.pub2-BIB22|cit22","doi-asserted-by":"crossref","unstructured":"Creasy G Hall N Shangold G Patient adherence with the contraceptive patch dosing schedule versus oral contraceptives Obstetrics & Gynecology 2000 S60","DOI":"10.1016\/S0029-7844(00)00716-X"},{"key":"10.1002\/14651858.CD003552.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1093\/humrep\/deh493","article-title":"Ovarian function with the contraceptive vaginal ring or an oral contraceptive: a randomized study","volume":"19","author":"Duijkers","year":"2004","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003552.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1093\/humrep\/deh494","article-title":"Follicular growth during contraceptive pill or vaginal ring treatment depends on the day of ovulation in the pretreatment cycle","volume":"19","author":"Duijkers","year":"2004","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003552.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0020-7292(00)85159-0","article-title":"Comparison of the effects of a contraceptive patch and oral contraceptives on coagulation parameters [abstract no. FC2.30.04]","volume":"70","author":"Kluft","year":"2000","journal-title":"International Journal of Gynaecology and Obstetrics"},{"key":"10.1002\/14651858.CD003552.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0015-0282(01)01689-2","article-title":"Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition","volume":"75","author":"Mulders","year":"2001","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD003552.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0020-7292(00)85163-2","article-title":"Effects of a contraceptive patch and 3 oral contraceptives on follicular development following incorrect dosing [abstract no. FC2.30.08]","volume":"70","author":"Pierson","year":"2000","journal-title":"International Journal of Gynaecology and Obstetrics"},{"key":"10.1002\/14651858.CD003552.pub2-BIB28|cit28","first-page":"34","article-title":"Ortho Evra\/Evra versus oral contraceptives: follicular development and ovulation in normal cycles and after an intentional dosing error","volume":"80","author":"Pierson","year":"2003","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD003552.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.fertnstert.2005.06.040","article-title":"Comparison of uterine concentrations of ethinyl estradiol and etonogestrel after use of a contraceptive vaginal ring and an oral contraceptive","volume":"85","author":"Roumen","year":"2006","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD003552.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0015-0282(01)03264-2","article-title":"A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra\u2122\/Evra\u2122)","volume":"77","author":"Sibai","year":"2002","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD003552.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00003088-200039030-00005","article-title":"Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring","volume":"39","author":"Timmer","year":"2000","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1002\/14651858.CD003552.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.contraception.2005.03.005","article-title":"Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive","volume":"72","author":"Heuvel","year":"2005","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD003552.pub2-BIB34|cit33","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/j.ajog.2005.02.067","article-title":"Effect of oral versus transdermal steroidal contraceptives on androgenic markers","volume":"192","author":"White","year":"2005","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD003552.pub2-BIB33|cit34","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.contraception.2006.04.005","article-title":"Effects of transdermal and oral contraceptives on estrogen-sensitive hepatic proteins","volume":"74","author":"White","year":"2006","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD003552.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0015-0282(01)03262-9","article-title":"Intergrated summary of Ortho Evra\u2122\/Evra\u2122 contraceptive patch adhesion in varied climates and conditions","volume":"77","author":"Zacur","year":"2002","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD003552.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0015-0282(01)03275-7","article-title":"Contraceptive efficacy and cycle control with the Ortho Evra\u2122\/Evra\u2122 transdermal system","volume":"77","author":"Zieman","year":"2002","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD003552.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/jama.290.7.921","article-title":"Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?","volume":"290","author":"Als-Nielsen","year":"2003","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD003552.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/9780470693926.ch15","article-title":"Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis","volume-title":"Systematic Reviews in Health Care: Meta-analysis in Context","author":"Deeks","year":"2001"},{"key":"10.1002\/14651858.CD003552.pub2-BIB39|cit39","unstructured":"US Food Drug Administration Higher Estrogen Exposure with Ortho Evra Contraceptive Patch http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/psn\/printer.cfm?id=392"},{"key":"10.1002\/14651858.CD003552.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/009286159803200102","article-title":"Technologies for automating randomized treatment assignment in clinical trials","volume":"32","author":"Haag","year":"1998","journal-title":"Drug Information Journal"},{"key":"10.1002\/14651858.CD003552.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","article-title":"Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study","volume":"143","author":"Heit","year":"2005","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD003552.pub2-BIB42|cit42","first-page":"101","article-title":"Pharmacology of progestins: 17alpha-hydroxyprogesterone derivatives and progestins of the first and second generation","volume-title":"Progestins and Antiprogestins in Clinical Practice","author":"Henzl","year":"2000"},{"key":"10.1002\/14651858.CD003552.pub2-BIB43|cit43","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005] www.cochrane.dk\/cochrane\/handbook\/hbook.htm"},{"key":"10.1002\/14651858.CD003552.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/bmj.326.7400.1167","article-title":"Pharmaceutical industry sponsorship and research outcome and quality: systematic review","volume":"326","author":"Lexchin","year":"2003","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD003552.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(00)04337-3","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"357","author":"Moher","year":"2001","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003552.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"1-11; discussio","DOI":"10.1002\/sim.1328","article-title":"ICH E9 guideline 'Statistical principles for clinical trials': a case study","volume":"22","author":"Phillips","year":"2003","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD003552.pub2-BIB47|cit47","unstructured":"Population Council Product research and development: female contraceptives http:\/\/www.popcouncil.org\/biomed\/femalecontras.html"},{"key":"10.1002\/14651858.CD003552.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2307\/2136191","article-title":"Measuring compliance among oral contraceptive users","volume":"28","author":"Potter","year":"1996","journal-title":"Family Planning Perspectives"},{"key":"10.1002\/14651858.CD003552.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/ije\/31.1.150","article-title":"Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed","volume":"31","author":"Robinson","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD003552.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2307\/2991665","article-title":"Compliance, counseling and satisfaction with oral contraceptives: a prospective evaluation","volume":"30","author":"Rosenberg","year":"1998","journal-title":"Family Planning Perspectives"},{"key":"10.1002\/14651858.CD003552.pub2-BIB51|cit51","volume-title":"Evidence-based Medicine: How to Practice and Teach EBM","author":"Sackett","year":"2000"},{"key":"10.1002\/14651858.CD003552.pub2-BIB52|cit52","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD003552.pub2-BIB53|cit53","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(02)07750-4","article-title":"Allocation concealment in randomised trials: defending against deciphering","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003552.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(02)07882-0","article-title":"Sample size slippages in randomised trials: exclusions and the lost and wayward","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003552.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0039-128X(03)00140-5","article-title":"Nestorone\u00ae: clinical applications for contraception and HRT","volume":"68","author":"Sitruk-Ware","year":"2003","journal-title":"Steroids"},{"key":"10.1002\/14651858.CD003552.pub2-BIB56|cit56","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.contraception.2004.03.009","article-title":"Contraceptive failure in the United States","volume":"70","author":"Trussell","year":"2004","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD003552.pub2-BIB57|cit57","first-page":"519","article-title":"Clinical epidemiology","volume-title":"Modern Epidemiology","author":"Weiss","year":"1998"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD003552.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:22:35Z","timestamp":1628529755000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003552.pub2"}},"subtitle":[],"editor":[{"given":"Laureen M","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2008,1,23]]},"references-count":57,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003552.pub2","relation":{},"subject":[],"published":{"date-parts":[[2008,1,23]]}}}